Log in with your NetID to export as a spreadsheet. After you log in, you will need to re-select any search options you've chosen.
| Deadline | Title | Funding Agency | Discipline | Who's Eligible |
Award Amount |
Date Posted |
|---|---|---|---|---|---|---|
| Deadline: 3/30/2022 | U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trials Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 10/05/2023 | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/31/2023 |
| Deadline: 2/16/2021 | Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 4/30/2021 | Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS-funded Center and Core Facilities | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 1/01/2022 | Notice of Intent to Publish a Suite of Funding Opportunity Announcements (FOAs) for the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 11/02/2021 | Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 6/05/2022 | Notice of Special Interest (NOSI): Research in the Emergency Setting | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 3/24/2022 |
| Deadline: 7/14/2021 | Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 11/10/2020 | Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 6/22/2023 | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 6/26/2023 |
| Deadline: 12/01/2022 | Contraceptive Development Research Center (P50 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 8/02/2022 |
| Deadline: 12/01/2020 | Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 10/17/2022 | Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/05/2022 |
| Deadline: 1/07/2022 | Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/28/2020 | Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 6/08/2020 | Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 7/09/2021 | Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 2/16/2021 | Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
| Deadline: 10/05/2023 | Notice of Special Interest (NOSI): Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 7/19/2023 |
| Deadline: 11/10/2020 | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs | National Institutes of Health |
Discipline:
|
Who's Eligible:
|
Award Amount: See solicitation for details | 4/18/2022 |
